Correlation Between Im Cannabis and Curative Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Im Cannabis and Curative Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Im Cannabis and Curative Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Im Cannabis Corp and Curative Biotechnology, you can compare the effects of market volatilities on Im Cannabis and Curative Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Im Cannabis with a short position of Curative Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Im Cannabis and Curative Biotechnology.

Diversification Opportunities for Im Cannabis and Curative Biotechnology

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between IMCC and Curative is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Im Cannabis Corp and Curative Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biotechnology and Im Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Im Cannabis Corp are associated (or correlated) with Curative Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biotechnology has no effect on the direction of Im Cannabis i.e., Im Cannabis and Curative Biotechnology go up and down completely randomly.

Pair Corralation between Im Cannabis and Curative Biotechnology

Given the investment horizon of 90 days Im Cannabis Corp is expected to under-perform the Curative Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Im Cannabis Corp is 3.56 times less risky than Curative Biotechnology. The stock trades about -0.07 of its potential returns per unit of risk. The Curative Biotechnology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1.39  in Curative Biotechnology on December 20, 2024 and sell it today you would earn a total of  0.14  from holding Curative Biotechnology or generate 10.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Im Cannabis Corp  vs.  Curative Biotechnology

 Performance 
       Timeline  
Im Cannabis Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Im Cannabis Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Curative Biotechnology 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Curative Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental drivers, Curative Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Im Cannabis and Curative Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Im Cannabis and Curative Biotechnology

The main advantage of trading using opposite Im Cannabis and Curative Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Im Cannabis position performs unexpectedly, Curative Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biotechnology will offset losses from the drop in Curative Biotechnology's long position.
The idea behind Im Cannabis Corp and Curative Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes